Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Confirmatory Study of MCC-847 for the Treatment of Adult Asthma
jRCT2080220054Phase 3
- Sponsor
- Mitsubishi Tanabe Pharma Corporation
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of masilukast in asthma, sponsored by Mitsubishi Tanabe Pharma Corporation.
02
Drugs
masilukast
03
Conditions
asthma
Beyond the preview
Go deeper on jRCT2080220054.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220054.